TABLE 3

Quantified regional CMRglc (in μmol · 100 g−1· min−1) means and SDs within groups and conditions, with analysis of effects (from repeated-measures ANOVA)

RegionInsulin sensitive
Insulin resistant
P
SalineInsulinSalineInsulinGroupConditionGroup by condition
Ventral striate (right)27.18 ± 2.9934.90 ± 4.07*31.12 ± 6.3134.35 ± 4.920.4932.08E-050.017
Ventral striate (left)29.24 ± 3.6536.82 ± 3.65*30.84 ± 6.4035.76 ± 6.78*0.9232.44E-050.183
Cerebellum18.44 ± 1.9221.62 ± 2.05*20.99 ± 3.3722.47 ± 3.640.2662.21E-040.082
Amygdal (right)15.65 ± 2.8718.13 ± 2.0018.40 ± 2.2317.13 ± 4.500.5280.5290.069
Amygdala (left)17.65 ± 2.5520.00 ± 0.9620.14 ± 3.7321.09 ± 1.940.1460.0330.328
Prefrontal cortex25.03 ± 3.0833.61 ± 3.99*27.70 ± 7.2332.65 ± 6.03*0.7619.64E-070.031
  • Post-hoc analysis (saline vs. insulin, within-group paired t test):

  • *

    * P < 0.01;

  • P < 0.05.